spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

PCI Builds North American Clinical Sales Team

PCI Pharma Services

Philadelphia, USA – 29 August, 2017




Leading outsourcing services provider PCI Clinical Services has expanded its North American Clinical sales team with the appointment of Nadine DuChateau as Business Development Executive.

Following an extensive career in clinical development services with more than 15 years’ experience in the field, Nadine joins the PCI team to support the development of the company’s client base in the Midwest. Prior to PCI, Nadine spent two years at a leading contract development and manufacturing organization in the pharmaceutical and biotechnology sector.

At PCI, Nadine will be responsible for account management and territory growth for the company’s global clinical packaging and logistics services in the Midwest, maintaining and growing market share with key customers while developing new business and cross-selling PCI’s high potency oral solid manufacturing, commercial packaging and analytical testing services.

Welcoming Nadine to PCI, Tim Roberts, PCI North America Business Development Director, commented: “We are thrilled Nadine will be part of our team. She brings a wealth of experience and has a glowing record of accomplishments that she’s achieved over her career. We are looking forward to working with her here at PCI Clinical Services and her insightful contributions to the success of our clients.”

Nadine said: “I am excited for this new opportunity given PCI’s reputation as the market leader. I’m really looking forward to joining the team and leveraging my experience in my new role to deliver great results for both new and current clients.”

PCI has announced considerable investment in its Clinical Trials business over the past year, including the expansion of its Cold Chain infrastructure at its North American clinical logistics facility in Rockford, IL, expanding onsite cryogenic storage to complement its extensive refrigerated and frozen on-site storage. In addition, the company announced a significant site expansion of its Bridgend, Wales, UK clinical center of excellence, which recently reached practical completion. PCI’s Bridgend site specializes in a broad range of temperature controlled storage and distribution capabilities including cryogenic storage, complementing services at the Rockford site.

These developments follow PCI’s announcement of its site expansion for its drug development and clinical trial manufacturing center of excellence in Tredegar, Wales, UK, including the purchase of a fully contained Xcelodose 600 unit for contained development of potent compounds in early phase clinical study.

To find out more about PCI, please visit www.pciservices.com.

About PCI

The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over four decades in the healthcare business. Leading technology and continued investment enables us to address global development needs throughout the product life cycle — from Phase I clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives. For more information, please visit www.pciservices.com or follow us on Twitter at @PCI_Social.

Contact


Chantel Richman / Fotini Efstathiou at Remarkable Content
chantel.richman@remarkablegroup.co.uk / Fotini@remarkablegroup.co.uk

T: 0117 247 0158 / 01962 853 929
phone +44 (0)1495 713 633
email sales@pciservices.com
web www.pciservices.com
email Wye Valley Business Park, Hay-on-Wye, HR3 5PG
 
Print this page
Send to a friend
   
spacer
News and Press Releases

World-leading cancer stem cell expert joins Avacta Scientific Advisory Board

Developer of biotherapeutics and research reagents announces the appointment of Professor Gerard Evan to its Scientific Advisory Board
More info >>


White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>

Industry Events

ASPIRE: International EDGE Conference

28 February - 1 March 2018, The Vox Conference Centre, Birmingham

The ASPIRE international conference is taking place on the 28th February and 1st March 2018 at the Vox Conference Centre in Birmingham. The conference brings together members of the research community including research professionals from the NHS, Clinical Trial Networks and international organisations. The ASPIRE conference will allow delegates to share knowledge and best practise with the focus on enhancing the efficiency and productivity of clinical research across the UK and beyond.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement